Back to Newsroom
Back to Newsroom

First-in-Class Biologic Eye Drop Regener-Eyes(R) Announces New Clinical Advisory Board Member Dr. Choate

Thursday, March 18, 2021 2:25 PM

PALM HARBOR, FL / ACCESSWIRE / March 18, 2021 / Regener-Eyes®, a leading first-in-class biologic eye drop made of naturally-occurring cytokines and growth factors, announced today the addition of Dr. Choate to its Clinical Advisory Board.

Regener-Eyes®, Thursday, March 18, 2021, Press release picture

"We are excited to have Dr. Choate join our clinical advisory board. He is a highly respected eye care professional and will bring valuable insight to our company's efforts," commented C. Randall Harrell, M.D., CEO and Founder of Regener-Eyes®. "We are honored to add Dr. Choate to our existing board alongside our other impressive members, Dr. Marguerite McDonald, Dr. Eric Donnenfeld, Dr. Paul Karpecki, Dr. Walt Whitley, Dr. Scott Schacter, Dr. Ahmed Fahmy, Dr. Art Epstein, and Dr. Sandra Cremers."

Dr. Choate is the founder and CEO of Choate Eye Associates, PLC in Nashville, TN. The focus of his practice is ocular disease, specialty contact lenses, and dry eye treatment and management. He is an Adjunct Associate Professor at the University of St. Louis College of Optometry. Dr. Choate is recognized for his participation in contact lenses, devices, and pharmaceutical clinical trials. He is a recognized speaker at national and international eye care meetings. He serves on the Editorial Advisory Boards of Primary Care Optometry News as well as Review of Optometry. Active in the profession, he is a member of the AOA and founding member of the AOA Contact Lens Section. He is also a Fellow of the American Academy of Optometry and the National Academy of Practices.

About Regener-Eyes®

Regener-Eyes® is a sterile biologic eye drop made of anti-inflammatory cytokines and growth factors. These types of proteins have been shown to reduce inflammation and stimulate the ocular surface to heal, repair, and regenerate. If you have patients that are not responding to current dry eye drugs, amniotic membrane intolerant, or having issues with blood serum tears, many physicians are finding success with Regener-Eyes® as a new option. For more information on our first in class biologic eye drop, please visit us at, follow us on Instagram, like us on Facebook, and connect with us on LinkedIn.

Contact Information:

Regener-Eyes®, LLC
Heidi Hart Pukas
[email protected]

SOURCE: Regener-Eyes®

Company Update
Back to newsroom
Back to Newsroom